ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

Morphine or Ketamine for Analgesia

ClinicalTrials.gov ID: NCT06835504

Public ClinicalTrials.gov record NCT06835504. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy of Intravenous Sub-Dissociative Ketamine Versus Intravenous Morphine in Children With Acute Pain

Study identification

NCT ID
NCT06835504
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Columbia University
Other
Enrollment
1,010 participants

Conditions and interventions

Interventions

  • Ketamine hydrochloride Drug
  • Morphine sulphate Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2026
Primary completion
Apr 29, 2029
Completion
Oct 30, 2029
Last update posted
Jan 25, 2026

2026 – 2029

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027
UC Davis Children's Hospital Sacramento California 95817
Nemours Children's Hospital Wilmington Delaware 19803
Arthur M. Blank Hospital Atlanta Georgia 30329
NewYork Presbyterian Morgan Stanley Children's Hospital New York New York 10032
UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224
Seattle Children's Hospital Seattle Washington 98105
Children's Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06835504, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 25, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06835504 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →